Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Subscribe To Our Newsletter & Stay Updated
